| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Urological Cancer Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90033
Alterations in DNA methylation patterns accompany the establishment of immortal cell lines. De novo methylation of CpG islands within the control regions of growth-regulatory genes may inactivate their transcription, giving cells selective growth advantages in culture. We exposed seven human tumor cell lines and two human fibroblast cell strains to the demethylating agent, 5-aza-2'-deoxycytidine (5-Aza-CdR), to determine whether the silencing of growth-regulatory genes by de novo methylation in immortalized cell lines could be reversed, possibly restoring growth control. After recovery from the immediate cytotoxic effects of 5-Aza-CdR, this agent suppressed cellular growth in all seven tumor lines but not in either fibroblast strain. Because alterations in the p16 (CDKN2/MTS1) cell cycle regulatory gene are associated with numerous cancers, we analyzed expression of this gene before and after 5-Aza-CdR treatment. The gene was reactivated by 5-Aza-CdR treatment in three of four tumor cell lines not expressing p16, whereas the fourth tumor line contained a p16 homozygous deletion. p16 was shown to be hypermethylated only in the cell lines and its up-regulation by 5-Aza-CdR was associated with demethylation of the p16 promoter. The remaining tumor lines expressed p16 at constant levels before and after 5-Aza-CdR treatment and showed minimal p16 promoter methylation, suggesting that other growth-regulatory genes may have been silenced by de novo methylation in these cells. p16 expression, cell growth inhibition, and G1 cell cycle arrest by 5-Aza-CdR in the T24 bladder tumor cell line were also heritable after prolonged passage in culture. Furthermore, a dormant p16 gene was reactivated in T24 cells growing in nu/nu rats, and 5-Aza-CdR treatment of T24 cells before inoculation into nu/nu mice decreased the rate of tumor growth. These results suggest that 5-Aza-CdR may slow the growth of tumor cells by reactivating growth-regulatory genes silenced by de novo methylation.
1 Supported by USPHS Grant R37 CA49758 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, Urological Cancer Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, 1441 Eastlake Avenue, Los Angeles, California 90033. Phone: (213) 764-0816; Fax: (213) 764-0102.
Received 9/16/97. Accepted 10/29/97.
This article has been cited by other articles:
|
|
 |
|
  E.-S. Lee, J.-P. Issa, D. B. Roberts, M. D. Williams, R. S. Weber, M. S. Kies, and A. K. El-Naggar Quantitative Promoter Hypermethylation Analysis of Cancer-Related Genes in Salivary Gland Carcinomas: Comparison with Methylation-Specific PCR Technique and Clinical Significance Clin. Cancer Res., May 1, 2008; 14(9): 2664 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Palii, B. O. Van Emburgh, U. T. Sankpal, K. D. Brown, and K. D. Robertson DNA Methylation Inhibitor 5-Aza-2'-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B Mol. Cell. Biol., January 15, 2008; 28(2): 752 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, K. Li, L. Wei, Z. Li, P. Yu, L. Teng, K. Wu, and J. Zhu p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma J. Clin. Pathol., November 1, 2007; 60(11): 1249 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Allegrucci, Y.-Z. Wu, A. Thurston, C. N. Denning, H. Priddle, C. L. Mummery, D. Ward-van Oostwaard, P. W. Andrews, M. Stojkovic, N. Smith, et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome Hum. Mol. Genet., May 15, 2007; 16(10): 1253 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M.E.I. Hellebrekers, V. Melotte, E. Vire, E. Langenkamp, G. Molema, F. Fuks, J. G. Herman, W. Van Criekinge, A. W. Griffioen, and M. van Engeland Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells Cancer Res., May 1, 2007; 67(9): 4138 - 4148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Agoston, P. Argani, A. M. De Marzo, J. L. Hicks, and W. G. Nelson Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting Complex Am. J. Pathol., May 1, 2007; 170(5): 1585 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ripperger, N. von Neuhoff, K. Kamphues, M. Emura, U. Lehmann, M. Tauscher, M. Schraders, P. Groenen, B. Skawran, C. Rudolph, et al. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle cell lymphomas Haematologica, April 1, 2007; 92(4): 460 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, S. Liu, Z. Xie, W. Blum, D. Perrotti, P. Paschka, R. Klisovic, J. Byrd, K. K. Chan, and G. Marcucci Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method Nucleic Acids Res., March 12, 2007; 35(5): e31 - e31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Egger, A. M. Aparicio, S. G. Escobar, and P. A. Jones Inhibition of Histone Deacetylation Does Not Block Resilencing of p16 after 5-Aza-2'-Deoxycytidine Treatment Cancer Res., January 1, 2007; 67(1): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-Y. Kim, S. Zhong, C. R. Fields, J. H. Kim, and K. D. Robertson Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res., August 1, 2006; 66(15): 7490 - 7501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. S. Guo, J. A. Hong, K. R. Irvine, G. A. Chen, P. J. Spiess, Y. Liu, G. Zeng, J. R. Wunderlich, D. M. Nguyen, N. P. Restifo, et al. De novo Induction of a Cancer/Testis Antigen by 5-Aza-2'-Deoxycytidine Augments Adoptive Immunotherapy in a Murine Tumor Model Cancer Res., January 15, 2006; 66(2): 1105 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lyko and R. Brown DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies J Natl Cancer Inst, October 19, 2005; 97(20): 1498 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Agoston, P. Argani, S. Yegnasubramanian, A. M. De Marzo, M. A. Ansari-Lari, J. L. Hicks, N. E. Davidson, and W. G. Nelson Increased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer J. Biol. Chem., May 6, 2005; 280(18): 18302 - 18310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Alleman, R. L. Tabios, G. V. R. Chandramouli, O. N. Aprelikova, C. Torres-Cabala, A. Mendoza, C. Rodgers, N. A. Sopko, W. M. Linehan, and J. R. Vasselli The In vitro and In vivo Effects of Re-Expressing Methylated von Hippel-Lindau Tumor Suppressor Gene in Clear Cell Renal Carcinoma with 5-Aza-2'-deoxycytidine Clin. Cancer Res., October 15, 2004; 10(20): 7011 - 7021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gemmati, A. Ongaro, G. L. Scapoli, M. Della Porta, S. Tognazzo, M. L. Serino, E. Di Bona, F. Rodeghiero, G. Gilli, R. Reverberi, et al. Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin's Lymphoma in Adults Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 787 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Suzuki, N. Sunaga, D. S. Shames, S. Toyooka, A. F. Gazdar, and J. D. Minna RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells Cancer Res., May 1, 2004; 64(9): 3137 - 3143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Youssef, D. Lotan, J.-P. Issa, K. Wakasa, Y.-H. Fan, L. Mao, K. Hassan, L. Feng, J. J. Lee, S. M. Lippman, et al. Hypermethylation of the Retinoic Acid Receptor-{beta}2 Gene in Head and Neck Carcinogenesis Clin. Cancer Res., March 1, 2004; 10(5): 1733 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. J. Issa, G. Garcia-Manero, F. J. Giles, R. Mannari, D. Thomas, S. Faderl, E. Bayar, J. Lyons, C. S. Rosenfeld, J. Cortes, et al. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies Blood, March 1, 2004; 103(5): 1635 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Karpf, A. W. Lasek, T. O. Ririe, A. N. Hanks, D. Grossman, and D. A. Jones Limited Gene Activation in Tumor and Normal Epithelial Cells Treated with the DNA Methyltransferase Inhibitor 5-Aza-2'-deoxycytidine Mol. Pharmacol., January 1, 2004; 65(1): 18 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Z. Fang, Y. Wang, N. Ai, Z. Hou, Y. Sun, H. Lu, W. Welsh, and C. S. Yang Tea Polyphenol (-)-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines Cancer Res., November 15, 2003; 63(22): 7563 - 7570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Grassi, P. Maccaroni, R. Meyer, H. Kaiser, E. D'Ambrosio, E. Pascale, M. Grassi, A. Kuhn, P. Di Nardo, R. Kandolf, et al. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87 Carcinogenesis, October 1, 2003; 24(10): 1625 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sato, A. Maitra, N. Fukushima, N. T. van Heek, H. Matsubayashi, C. A. Iacobuzio-Donahue, C. Rosty, and M. Goggins Frequent Hypomethylation of Multiple Genes Overexpressed in Pancreatic Ductal Adenocarcinoma Cancer Res., July 15, 2003; 63(14): 4158 - 4166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Segura-Pacheco, C. Trejo-Becerril, E. Perez-Cardenas, L. Taja-Chayeb, I. Mariscal, A. Chavez, C. Acuna, A. M. Salazar, M. Lizano, and A. Duenas-Gonzalez Reactivation of Tumor Suppressor Genes by the Cardiovascular Drugs Hydralazine and Procainamide and Their Potential Use in Cancer Therapy Clin. Cancer Res., May 1, 2003; 9(5): 1596 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Milutinovic, Q. Zhuang, A. Niveleau, and M. Szyf Epigenomic Stress Response. KNOCKDOWN OF DNA METHYLTRANSFERASE 1 TRIGGERS AN INTRA-S-PHASE ARREST OF DNA REPLICATION AND INDUCTION OF STRESS RESPONSE GENES J. Biol. Chem., April 18, 2003; 278(17): 14985 - 14995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Cheng, C. B. Matsen, F. A. Gonzales, W. Ye, S. Greer, V. E. Marquez, P. A. Jones, and E. U. Selker Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine J Natl Cancer Inst, March 5, 2003; 95(5): 399 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Paz, M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman, and M. Esteller A Systematic Profile of DNA Methylation in Human Cancer Cell Lines Cancer Res., March 1, 2003; 63(5): 1114 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sato, N. Maehara, G. H. Su, and M. Goggins Effects of 5-Aza-2'-deoxycytidine on Matrix Metalloproteinase Expression and Pancreatic Cancer Cell Invasiveness J Natl Cancer Inst, February 19, 2003; 95(4): 327 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Nguyen, D. J. Weisenberger, M. Velicescu, F. A. Gonzales, J. C. Y. Lin, G. Liang, and P. A. Jones Histone H3-Lysine 9 Methylation Is Associated with Aberrant Gene Silencing in Cancer Cells and Is Rapidly Reversed by 5-Aza-2'-deoxycytidine Cancer Res., November 15, 2002; 62(22): 6456 - 6461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Goffin and E. Eisenhauer DNA methyltransferase inhibitors--state of the art Ann. Onc., November 1, 2002; 13(11): 1699 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Daskalakis, T. T. Nguyen, C. Nguyen, P. Guldberg, G. Kohler, P. Wijermans, P. A. Jones, and M. Lubbert Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment Blood, September 26, 2002; 100(8): 2957 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Suh, C. S. Ha, E. B. Rankin, M. Toyota, and P. G. Traber DNA Methylation Down-regulates CDX1 Gene Expression in Colorectal Cancer Cell Lines J. Biol. Chem., September 20, 2002; 277(39): 35795 - 35800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Velicescu, D. J. Weisenberger, F. A. Gonzales, Y. C. Tsai, C. T. Nguyen, and P. A. Jones Cell Division Is Required for de Novo Methylation of CpG Islands in Bladder Cancer Cells Cancer Res., April 1, 2002; 62(8): 2378 - 2384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liang, F. A. Gonzales, P. A. Jones, T. F. Orntoft, and T. Thykjaer Analysis of Gene Induction in Human Fibroblasts and Bladder Cancer Cells Exposed to the Methylation Inhibitor 5-Aza-2'-deoxycytidine Cancer Res., February 1, 2002; 62(4): 961 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Heckert and M. D. Griswold The Expression of the Follicle-stimulating Hormone Receptor in Spermatogenesis Recent Prog. Horm. Res., January 1, 2002; 57(1): 129 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Widschwendter and P. A. Jones The Potential Prognostic, Predictive, and Therapeutic Values of DNA Methylation in Cancer : Commentary re: J. Kwong et al., Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients. Clin. Cancer Res., 8: 188-191, 2002. Clin. Cancer Res., January 1, 2002; 8(1): 17 - 21. [Full Text] [PDF]
|
|
|
|
|
|
M. Sekimata, A. Takahashi, A. Murakami-Sekimata, and Y. Homma Involvement of a Novel Zinc Finger Protein, MIZF, in Transcriptional Repression by Interacting with a Methyl-CpG-binding Protein, MBD2 J. Biol. Chem., November 9, 2001; 276(46): 42632 - 42638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Worm, A. F. Kirkin, K. N. Dzhandzhugazyan, and P. Guldberg Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer Cells J. Biol. Chem., October 19, 2001; 276(43): 39990 - 40000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Simpson, S. J. Frost, J. E. Bicknell, J. C. Broome, A. M. McNicol, R. N. Clayton, and W. E. Farrell Aberrant expression of G1/S regulators is a frequent event in sporadic pituitary adenomas Carcinogenesis, August 1, 2001; 22(8): 1149 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lubomierski, M. Kersting, T. Bert, K. Muench, U. Wulbrand, M. Schuermann, D. Bartsch, and B. Simon Tumor Suppressor Genes in the 9p21 Gene Cluster Are Selective Targets of Inactivation in Neuroendocrine Gastroenteropancreatic Tumors Cancer Res., August 1, 2001; 61(15): 5905 - 5910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Venkatasubbarao, S. Ammanamanchi, M. G. Brattain, D. Mimari, and J. W. Freeman Reversion of Transcriptional Repression of Sp1 by 5 aza-2' Deoxycytidine Restores TGF-{beta} Type II Receptor Expression in the Pancreatic Cancer Cell Line MIA PaCa-2 Cancer Res., August 1, 2001; 61(16): 6239 - 6247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Karpf, B. C. Moore, T. O. Ririe, and D. A. Jones Activation of the p53 DNA Damage Response Pathway after Inhibition of DNA Methyltransferase by 5-Aza-2'-deoxycytidine Mol. Pharmacol., April 1, 2001; 59(4): 751 - 757. [Abstract] [Full Text]
|
|
|
|
|
|
M. T. Hartsough, S. E. Clare, M. Mair, A. G. Elkahloun, D. Sgroi, C. K. Osborne, G. Clark, and P. S. Steeg Elevation of Breast Carcinoma Nm23-H1 Metastasis Suppressor Gene Expression and Reduced Motility by DNA Methylation Inhibition Cancer Res., March 1, 2001; 61(5): 2320 - 2327. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. D. Griswold and J.-S. Kim Site-Specific Methylation of the Promoter Alters Deoxyribonucleic Acid-Protein Interactions and Prevents Follicle-Stimulating Hormone Receptor Gene Transcription Biol Reprod, February 1, 2001; 64(2): 602 - 610. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yoshida, H. Eguchi, K. Nakachi, K. Tanimoto, Y. Higashi, K. Suemasu, Y. Iino, Y. Morishita, and S.-i. Hayashi Distinct mechanisms of loss of estrogen receptor {{alpha}} gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors Carcinogenesis, December 1, 2000; 21(12): 2193 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Plumb, G. Strathdee, J. Sludden, S. B. Kaye, and R. Brown Reversal of Drug Resistance in Human Tumor Xenografts by 2'-Deoxy-5-azacytidine-induced Demethylation of the hMLH1 Gene Promoter Cancer Res., November 1, 2000; 60(21): 6039 - 6044. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Patel, C. H. Anna, J. F. Foley, P. S. Stockton, F. L. Tyson, J.C. Barrett, and T. R. Devereux Hypermethylation of the p16 Ink4a promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines Carcinogenesis, September 1, 2000; 21(9): 1691 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chen, L. He, V. H. Savell, J. J. Jenkins, and D. M. Parham Inhibition of the Interferon-{{gamma}}/Signal Transducers and Activators of Transcription (STAT) Pathway by Hypermethylation at a STAT-binding Site in the p21WAF1 Promoter Region Cancer Res., June 1, 2000; 60(12): 3290 - 3298. [Abstract] [Full Text]
|
|
|
|
|
|
C. Müller, C. Readhead, S. Diederichs, G. Idos, R. Yang, N. Tidow, H. Serve, W. E. Berdel, and H. P. Koeffler Methylation of the Cyclin A1 Promoter Correlates with Gene Silencing in Somatic Cell Lines, while Tissue-Specific Expression of Cyclin A1 Is Methylation Independent Mol. Cell. Biol., May 1, 2000; 20(9): 3316 - 3329. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Eads, K. D. Danenberg, K. Kawakami, L. B. Saltz, C. Blake, D. Shibata, P. V. Danenberg, and P. W. Laird MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Res., April 15, 2000; 28(8): e32 - e. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. dos Santos, R. Torensma, T. J. de Vries, M. W. J. Schreurs, D. R. H. de Bruijn, E. Kater-Baats, D. J. Ruiter, G. J. Adema, G. N. P. van Muijen, and A. G. van Kessel Heterogeneous Expression of the SSX Cancer/Testis Antigens in Human Melanoma Lesions and Cell Lines Cancer Res., March 1, 2000; 60(6): 1654 - 1662. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Guan, H. L. Ford, Y. Fu, Y. Li, L. M. Shaw, and A. B. Pardee Drg-1 as a Differentiation-related, Putative Metastatic Suppressor Gene in Human Colon Cancer Cancer Res., February 1, 2000; 60(3): 749 - 755. [Abstract] [Full Text]
|
|
|
|
|
|
T. J.King, L. H.Fukushima, T. A.Donlon, A.D. Hieber, K. A.Shimabukuro, and J. S.Bertram Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: implications for tumor progression Carcinogenesis, February 1, 2000; 21(2): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nosaka, M. Maeda, S. Tamiya, T. Sakai, H. Mitsuya, and M. Matsuoka Increasing Methylation of the CDKN2A Gene Is Associated with the Progression of Adult T-Cell Leukemia Cancer Res., February 1, 2000; 60(4): 1043 - 1048. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Toyota, M. Ohe-Toyota, N. Ahuja, and J.-P. J. Issa Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype PNAS, January 18, 2000; 97(2): 710 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. TORRES, M. A. ÁVILA, M. V. CARRETERO, M. U. LATASA, J. CABALLERÍA, G. LÓPEZ-RODAS, A. BOUKABA, S. C. LU, L. FRANCO, and J. M. MATO Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation FASEB J, January 1, 2000; 14(1): 95 - 102. [Abstract] [Full Text]
|
|
|
|
|
|
A. R. Karpf, P. W. Peterson, J. T. Rawlins, B. K. Dalley, Q. Yang, H. Albertsen, and D. A. Jones Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells PNAS, November 23, 1999; 96(24): 14007 - 14012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Frost, D. J. Simpson, R. N. Clayton, and W. E. Farrell Transfection of an Inducible p16/CDKN2A Construct Mediates Reversible Growth Inhibition and G1 Arrest in the AtT20 Pituitary Tumor Cell Line Mol. Endocrinol., November 1, 1999; 13(11): 1801 - 1810. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Bender, M. L. Gonzalgo, F. A. Gonzales, C. T. Nguyen, K. D. Robertson, and P. A. Jones Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands Mol. Cell. Biol., October 1, 1999; 19(10): 6690 - 6698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ma, M. J. Stampfer, B. Christensen, E. Giovannucci, D. J. Hunter, J. Chen, W. C. Willett, J. Selhub, C. H. Hennekens, R. Gravel, et al. A Polymorphism of the Methionine Synthase Gene: Association with Plasma Folate, Vitamin B12, Homocyst(e)ine, and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 825 - 829. [Abstract] [Full Text]
|
